Treatment |
Study population and intervention |
Duration |
|
|
|
|
Free-living healthy senior subjects (Group 1). |
|
|
|
|
1 |
No intervention; Baseline (Males n = 20 + Females n = 10); Total (n) = 30 |
Weeks 1-4 (Phase I) |
2 |
Diet supplementation with NS-7; 2 capsules/d (Subgoup A) |
Weeks 5-8 (Phase II) |
3 |
No intervention; Baseline (Males n = 24 + Females n = 15); Total (n) = 39 |
Weeks 1-4 (Phase I) |
4 |
Diet supplementation with NS-6; 2 capsules/d (Subgroup B) |
Weeks 5-8 (Phase II) |
|
|
|
|
Hypercholesterolemic human subjects (Group 2) |
|
|
|
|
5 |
No intervention; Baseline (Males n = 32 + Females n = 9); Total (n) = 41 |
Weeks 1-4 (Phase I) |
6 |
Implementation of AHA Step-1 diet + NS-7, 2 capsules/d; (Subgroup C) |
Weeks 5-8 (Phase II) |
7 |
No intervention; Baseline (Males n = 20 + Females n = 10); Total (n) = 30 |
Weeks 1-4 (Phase I) |
8 |
Implementation of AHA Step-1 diet + NS-6, 2 capsules/d; (Subgoup D) |
Weeks 5-8 (Phase II) |